These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 6103724

  • 21. Increased suppressor cell activity in inflammatory bowel disease.
    Holdstock G, Chastenay BF, Krawitt EL.
    Gut; 1981 Dec; 22(12):1025-30. PubMed ID: 6119275
    [Abstract] [Full Text] [Related]

  • 22. Antagonism of tone and prostaglandin-mediated responses in a tracheal preparation by indomethacin and SC-19220.
    Farmer JB, Farrar DG, Wilson J.
    Br J Pharmacol; 1974 Dec; 52(4):559-65. PubMed ID: 4455330
    [Abstract] [Full Text] [Related]

  • 23. The effects of sulphasalazine and its metabolites on prostaglandin production by human mononuclear cells.
    Punchard NA, Boswell DJ, Greenfield SM, Thompson RP.
    Biochem Pharmacol; 1992 Jun 09; 43(11):2369-76. PubMed ID: 1351726
    [Abstract] [Full Text] [Related]

  • 24. Sulphasalazine and derivatives, natural killer activity and ulcerative colitis.
    Gibson PR, Jewell DP.
    Clin Sci (Lond); 1985 Aug 09; 69(2):177-84. PubMed ID: 2866061
    [Abstract] [Full Text] [Related]

  • 25. Soybean lipoxygenase inhibition: studies with the sulphasalazine metabolites N-acetylaminosalicylic acid, 5-aminosalicylic acid and sulphapyridine.
    Allgayer H, Eisenburg J, Paumgartner G.
    Eur J Clin Pharmacol; 1984 Aug 09; 26(4):449-51. PubMed ID: 6428914
    [Abstract] [Full Text] [Related]

  • 26. The protective effects of sulphasalazine against ethanol-induced gastric damage in rats.
    Cho CH, Ogle CW, Sevilla EL.
    Br J Pharmacol; 1987 Sep 09; 92(1):31-7. PubMed ID: 2889494
    [Abstract] [Full Text] [Related]

  • 27. Studies of prostaglandins and sulphasalazine in ulcerative colitis.
    Gould SR, Brash AR, Conolly ME, Lennard-Jones JE.
    Prostaglandins Med; 1981 Feb 09; 6(2):165-82. PubMed ID: 6113614
    [Abstract] [Full Text] [Related]

  • 28. Effect of indoprofen on prostaglandin and thromboxane A2 synthesis in the guinea pig lung.
    Ceserani R, Colombo M, Mandelli V.
    Prostaglandins Med; 1979 May 09; 2(5):337-42. PubMed ID: 550151
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of prostaglandin 15-hydroxydehydrogenase by sulphasalazine and a novel series of potent analogues.
    Berry CN, Hoult JR, Peers SH, Agback H.
    Biochem Pharmacol; 1983 Oct 01; 32(19):2863-71. PubMed ID: 6138042
    [Abstract] [Full Text] [Related]

  • 30. Sulphasalazine, olsalazine and sulphapyridine induce mitogenic actions in the rat intestinal epithelium.
    Benno P, Alam M, Midtvedt T, Uribe A.
    APMIS; 1997 Sep 01; 105(9):717-22. PubMed ID: 9350216
    [Abstract] [Full Text] [Related]

  • 31. Sulphasalazine and PhCL28A inhibit the formation of ethanol- and phenylbutazone-induced rat gastric ulcers: lack of involvement of endogenous prostaglandins?
    Berry CN, Prouteau M, Lloyd KG.
    Br J Pharmacol; 1988 Mar 01; 93(3):465-72. PubMed ID: 2897215
    [Abstract] [Full Text] [Related]

  • 32. The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects?
    Aruoma OI, Wasil M, Halliwell B, Hoey BM, Butler J.
    Biochem Pharmacol; 1987 Nov 01; 36(21):3739-42. PubMed ID: 2890355
    [Abstract] [Full Text] [Related]

  • 33. Kinetic measurements of the release of prostaglandins from perfused rat lungs.
    Anderson WG, Abou-Donia MB, Menzel DB.
    Prostaglandins; 1975 Nov 01; 10(5):779-88. PubMed ID: 1215540
    [Abstract] [Full Text] [Related]

  • 34. Inhibition of stress-induced gastric ulcers by sulphasalazine and its constituents (sulphapyridine and 5-aminosalicylic acid) in rats.
    Garg GP, Cho CH, Ogle CW.
    Pharmacology; 1990 Nov 01; 40(6):318-24. PubMed ID: 1978355
    [Abstract] [Full Text] [Related]

  • 35. Antagonism of arachidonic acid hydroperoxide on isolated gastrointestinal tissues as a measure of the inhibition of prostaglandin biosynthesis.
    Van Nueten JM.
    Adv Prostaglandin Thromboxane Res; 1976 Nov 01; 1():139-45. PubMed ID: 11650
    [Abstract] [Full Text] [Related]

  • 36. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues.
    Dong YJ, Jones RL, Wilson NH.
    Br J Pharmacol; 1986 Jan 01; 87(1):97-107. PubMed ID: 2420404
    [Abstract] [Full Text] [Related]

  • 37. Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.
    Lauritsen K, Hansen J, Bytzer P, Bukhave K, Rask-Madsen J.
    Gut; 1984 Nov 01; 25(11):1271-8. PubMed ID: 6149981
    [Abstract] [Full Text] [Related]

  • 38. Sulfasalazine and 5-aminosalicylic acid inhibit contractile leukotriene formation.
    Nielsen ST, Beninati L, Buonato CB.
    Scand J Gastroenterol; 1988 Apr 01; 23(3):272-6. PubMed ID: 2898806
    [Abstract] [Full Text] [Related]

  • 39. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.
    Klotz U.
    Clin Pharmacokinet; 1985 Apr 01; 10(4):285-302. PubMed ID: 2864155
    [Abstract] [Full Text] [Related]

  • 40. Sulphasalazine inhibition of human granulocyte activation by inhibition of second messenger compounds.
    Carlin G, Djursäter R, Smedegård G.
    Ann Rheum Dis; 1992 Nov 01; 51(11):1230-6. PubMed ID: 1361317
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.